T1	Participants 136 250	patients prescribed blood pressure or lipid-lowering drugs for the prevention of coronary heart disease and stroke
T2	Participants 444 535	303 patients taking blood pressure and/or lipid-lowering medications were randomly assigned
T3	Participants 1682 1785	patients taking blood pressure or lipid-lowering treatment for the prevention of cardiovascular disease
